1. Xu J#, Cao B*.Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19.Eur Respir J.2022.59(1).2102002.SCI |
2. Guo L#, Zhang Q, Zhang C, Huang T, Ren L, Cao B*, Wang J*.Assessment of Antibody and T-Cell Responses to the SARS-CoV-2 Virus and Omicron Variant in Unvaccinated Individuals Recovered From COVID-19 Infection in Wuhan, China.JAMA Netw Open.2022.5(4).e229199.SCI |
3. Huang Z#, Li H, Liu S, Jia J, Zheng Y, Cao B*.Identification of Neutrophil-Related Factor LCN2 for Predicting Severity of Patients With Influenza A Virus and SARS-CoV-2 Infection.Front Microbiol.2022.13.854172.SCI |
4. Han X#, Chen L, Li H, Zhou F, Xing X, Zhang C, Suo L, Wang J, Liu X*, Cao B*.Prognostic Factors for Cardiovascular Events in Elderly Patients with Community Acquired Pneumonia: Results from the CAP-China Network.Clin Interv Aging.2022.17.603-614.SCI |
5. Zhang Y#, Zhao J, Han J, Fan Y, Xiong Z, Zou X, Li B, Liu X, Li Z, Lu B*, Cao B*.Synergistic Activity of Imipenem in Combination with Ceftazidime/Avibactam or Avibactam against Non-MBL-Producing Extensively Drug-Resistant Pseudomonas aeruginosa.Microbiol Spectr.2022.10(2).e0274021.SCI |
6. Li H#, Zhao M#, Zhang H, Quan C, Zhang D, Liu Y, Liu M, Xue C, Tan S, Guo Y, Zhao Y, Wu G, Gao GF*, Cao B*, Liu WJ*.Pneumonia Severity and Phase Linked to Virus-Specific T Cell Responses with Distinct Immune Checkpoints during pH1N1 Infection.J Immunol.2022.208(9).2154-2162.SCI |
7. Guo L#, Wang G#, Wang Y#, Zhang Q#, Ren L#, Gu X, Huang T, Zhong J, Wang Y, Wang X, Huang L, Xu L, Wang C, Chen L, Xiao X, Peng Y, Knight JC, Dong T, Cao B*, Wang J*.SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.Lancet Microbe.2022.3(5).e348-e356.SCI |
8. Chang K#, Wang H#, Zhao J, Yang X, Wu B, Sun W, Huang M, Cheng Z, Chen H, Song Y, Chen P, Chen X, Gan X, Ma W, Xing L, Wang Y, Gu X, Zou X, Cao B*.Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii.Front Med (Lausanne).2022.9.772372.SCI |
9. Zhao J#, Li Z#, Zhang Y, Liu X, Lu B*, Cao B*.Convergence of MCR-8.2 and Chromosome-Mediated Resistance to Colistin and Tigecycline in an NDM-5-Producing ST656 Klebsiella pneumoniae Isolate From a Lung Transplant Patient in China.Front Cell Infect Microbiol.2022.12.922031.SCI |
10. Yang X#, Hou C, Shen Y, Zhang M, Zhang K, Wang F, Liu Y, Ma X, Cheng L, Kang J, Hu B, Wang M, Zeng L, Wang Y, He Y, Cao G, Jiang J, Jones P, Cao B*, Li L*.Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in China.JAMA Netw Open.2022.5(9).e2231790.SCI |
11. Zou X#, Suo L#, Wang Y#, Cao H#, Mu S, Wu C, Yan L, Qi X, Lu J, Lu B, Fan Y, Li H, Huang L, Ren L*, Liu B*, Cao B*.Concurrent pigeon paramyxovirus-1 and Acinetobacter baumannii infection in a fatal case of pneumonia.Emerg Microbes Infect.2022.11(1).968-977.SCI |
12. Yu J#, Li H, Jia J, Huang Z, Liu S, Zheng Y, Mu S, Deng X, Zou X, Wang Y, Shang X, Cui D, Huang L, Feng X, Liu W.J, Cao B*.Pandemic influenza A (H1N1) virus causes abortive infection of primary human T cells.Emerg Microbes Infect.2022.11(1).1191-1204.SCI |
13. Cui D#, Wang Y#, Huang L#, Gu X#, Huang Z, Mu S, Wang C*, Cao B*.Rheumatic Symptoms Following Coronavirus Disease 2019 (COVID-19): A Chronic Post-COVID-19 Condition.Open Forum Infect Dis.2022.9(6).ofac170.SCI |
14. Liu S#,, Huang Z#, Fan R, Jia J, Deng X, Zou X, Li H, Cao B*.Development and evaluation of a multiplex quantitative polymerase chain reaction assay for detecting bacteria associated with lower respiratory tract infection.Int J Infect Dis.2022.122.202-211.SCI |
15. Wang Z#, Deng T#, Zhang Y#, Niu W, Nie Q, Yang S, Liu P, Pei P, Chen L, Li H*, Cao B*.ACE2 can act as the secondary receptor in the FcgammaR-dependent ADE of SARS-CoV-2 infection.iScience.2022.25(1).103720.SCI |
16. Zhang H#, Li X#, Huang L#, Gu X#, Wang Y, Liu M, Liu Z, Zhang X, Yu Z, Wang Y*, Huang C*, Cao B*.Lung-function trajectories in COVID-19 survivors after discharge: A two-year longitudinal cohort study.EClinicalMedicine.2022.54.101668.SCI |
17. Cui D#, Chen S#, Feng L#, Jia M#, Wang Y#, Xiao W, Sun Y, Huang Q, Ma L, Leng Z, Wang H, Cao B*, Yang W*, Yang J*, Wang C*.Long-term outcomes in COVID-19 patients who recovered from the first wave of the pandemic.Natl Sci Rev.2022.9(11).nwac192.SCI |
18. Zou X#, Mu S#, Wang Y#, Guo L#, Ren L, Deng X, Li H, Zhao J, Zhang Y, Li H, Lu B, Huang C, Cao B*.Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients.Virol Sin.2022.37(1).30-37.SCI |
19. Zou X#, Suo L#, Wang Y#, Cao H#, Mu S, Wu C, Yan L, Qi X, Lu J, Lu B, Fan Y, Li H, Huang L, Ren L*, Liu B*, Cao B*.Concurrent pigeon paramyxovirus-1 and Acinetobacter baumannii infection in a fatal case of pneumonia.Emerg Microbes Infect.2022.11(1).968-977.SCI |
20. Chang K#, Wang H, Zhao J, Yang X, Wu B, Sun W, Huang M, Cheng Z, Chen H, Song Y, Chen P, Chen X, Gan X, Ma W, Xing L, Wang Y*, Cao B*.Risk factors for polymyxin B-associated acute kidney injury.Int J Infect Dis.2022.117.37-44.SCI |
21. Gu X#, Huang L, Cui D, Wang Y, Wang Y, Xu J, Shang L, Fan G, Cao B*.Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohort study.EBioMedicine.2022.76.103817.SCI |
22. Wang C#, Zhao J#, Liu Z#, Sun A#, Sun L, Li B, Lu B, Liu Y, Cao B*.In vivo Selection of Imipenem Resistance Among Ceftazidime-Avibactam-Resistant, Imipenem-Susceptible Klebsiella pneumoniae Isolate With KPC-33 Carbapenemase.Front Microbiol.2021.12.727946.SCI |
23. Li H#, Gu X#, Li H#, Gong F#, Xu J, Wang Y, Li H, Ruan S, Yang Q, Cao B*.Risk factors of viral RNAaemia and its association with clinical prognosis among patients with severe COVID-19.Chest.2021.159(4).1382-1386.SCI |
24. Huang C#, Huang L#, Wang Y#, Li X#, Ren L#, Gu X#, Kang L#, Guo L#, Liu M#, Zhou X, Luo J, Huang Z, Tu S, Zhao, Y, Chen L, Xu D, Li Y, L C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan g, Xu J, Wang G, Wang Y, Zhang J, Wang C, Wang J*, Zhang D*, Cao B*.6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.Lancet.2021.397(10270).220-232.SCI |
25. Xu J #,Cao B*.Managing the second‐wave COVID‐19 outbreak in Beijing.Respiratory.2021.26(3).275-276.SCI |
26. Liu S#, Huang Z#, Deng X, Zou X, Li H, Mu S, Cao B*.Identification of key candidate biomarkers for severe influenza infection by integrated bioinformatical analysis and initial clinical validation.J Cell Mol Med.2021.25(3).1725-1738.SCI |
27. Xu J﹟, Teng Y﹟, Shang L﹟, Gu X, Fan G, Chen Y, Tian R, Zhang S, Cao B*.The Effect of Prior ACEI/ARB Treatment on COVID-19 Susceptibility and Outcome: A Systematic Review and Meta-Analysis.Clin Infect Dis.2021.72(11).e901-e913.SCI |
28. Huang L#, Gu X, Cao B*.Long-term effects on survivors with COVID-19 reply.Lancet.2021.398(10314).31872-1873.SCI |
29. Yin H#, Gu X, Wang Y, Fan G, Lu B, Liu M, Wang C, Cao B*, Wang C.Clinical characteristics of patients with bronchiectasis with nontuberculous mycobacterial disease in Mainland China: a single center cross-sectional study.BMC Infect Dis.2021.21(1).1216.SCI |
30. Duan S#, Gu X, Fan G, Zhou F, Zhu G, Cao B*.C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections.BMC Pulm Med.2021.21(1).308.SCI |
31. Huang L#, Gu X, Wang Y, Huang C, Cao B*.Long-term effects of COVID-19 on kidney function Reply.Lancet.2021.397(10287).1807-1808.SCI |
32. Liu B#, Bao L#, Wang L#, Li F, Wen M, Li H, Deng W, Zhang X, Cao B*.Anti-IFN-gamma therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice.J Microbiol Immunol Infect.2021.54(3).396-403.SCI |
33. Ren L#, Wang Y#,, Zhong J#,, Li X, Xiao Y, Li J, Yang J, Fan G, Guo L, Shen Z, Kang L, Shi L, Li Q, Li J, Di L, Li H, Wang C, Wang Y, Wang X, Zou X, Rao J, Zhang L, Wang J, Huang Y, Cao B*, Wang J*, Li M*.Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19.Am J Respir Crit Care Med.2021.204(12).1379-1390.SCI |
34. Huang L#, Wang Ji, Gu Xi, Sheng W, Wang Y, Cao B*.Procalcitonin-guided initiation of antibiotics in AECOPD inpatients: study protocol for a multicenter randomised controlled trial.BMJ Open.2021.11(8).e049515.SCI |
35. Huang L#, Yao Q#, Gu X#, Wang Q#, Ren L#, Wang Y#, Hu P#, Guo L#, Liu M, Xu J, Zhang X, Qu Y, Fan Y, Li X, Li C, Yu T, Xia J, Wei M, Chen L, Li Y, Xiao F, Liu D, Wang J*, Wang X*, Cao B*.1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.Lancet.2021.398(10302).747-758.SCI |
36. Wu Xu#, Bao L#, Hu Z, Yao D, Li F, Li H, Xu X, An Y, Wang X, Cao B*, Zhang X*.Ficolin A exacerbates severe H1N1 influenza virus infection-induced acute lung immunopathological injury via excessive complement activation. Cell Mol Immunol.Cell Mol Immunol.2021.18(9).2278-2280.SCI |
37. Sun L#, Li H, Wang Q, Liu Y*, Cao B*.Increased gene expression and copy number of mutated bla(KPC) lead to high-level ceftazidime/avibactam resistance in Klebsiella pneumoniae.BMC Microbiol .2021.21(1).230.SCI |
38. Zou X#, Cao B*.COVID-19 vaccines for children younger than 12 years: are we ready? .Lancet Infect Dis.2021.21(12).1614-1615.SCI |
39. Gu X#, Zhou F, Wang Y, Fan G, Cao B*.Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment.Eur Respir Rev.2020.29(157).200038.SCI |
40. Cao B﹟*, Hayden FG.Antiviral monotherapy for hospitalised patients with COVID-19 is not enough.Lancet.2020.396(10259).1310-1311.SCI |
41. Wang Y#, Zhang D#, Du G#, Du R#, Zhao J# , Jin Y# , Fu S# , Gao L# , Cheng Z# , Lu Q# , Hu Y# , Luo G#, Wang K , Lu Y , Li H , Wang S , Ruan S , Yang C , Mei C , Wang Y , Ding D , Wu F , Tang X , Ye X , Ye Y , Liu B , Yang J , Yin W , Wang A , Fan G , Zhou F , Liu Z , Gu X , Xu J , Shang L, Zhang.Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.Lancet.2020.395(10236).1569-1578.SCI |
42. Zhou F#, Yu T#, Du R#, Fan G#, Liu Y#, Liu Z#, Xiang J#, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H*, Cao B*.Clinical course and risk factors for mortality of adult inpatients with SARS-CoV-2 Pneumonia.Lancet.2020.395(10229).1054-1062.SCI |
43. Wang Y#, Zhou F, Zhang D, Zhao J, Du R, Hu Y, Cheng Z, Gao L, Jin Y, Luo G, Fu S, Lu Q, Du G, Wang K, Lu Y, Fan G, Zhang Y, Liu Y, Ruan S, Liu W, Thomas Jaki, Frederick G Hayden, Peter W Horby, Cao B* , Wang C*.Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.Trials.2020.21(1).422.SCI |
44. Sun L#, Chen W#, Li H# , Li L#, Zou X , Zhao J, Lu B , Li B, Wang C , Li H , Liu Y, Cao B*.Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background.J Antimicrob Chemother.2020.75(10).3072-3074.SCI |
45. Cui X#, Gao L#, Cao B*.Management of Latent Tuberculosis Infection in China: Exploring solutions suitable for high-burden countries.Int J Infect Dis.2020.92S.S37-S40.SCI |
46. Yin H#, Wang S# , Qu J , Zhou F , Wang C* , Cao B* , For CAP-China.Long-term prognosis of adolescent and middle-aged Chinese patients with low-medium risk community-acquired pneumonia: a cohort study.Clin Respir J.2020.14(10).933-939.SCI |
47. Zhao J#, Liu C, Liu Y, Zhang Y, Xiong Z, Fan Y, Zou X, Lu B, Cao B*.Genomic characteristics of clinical important ST11 Klebsiella pneumoniaeworldwide.J Glob Antimicrob Resist.2020.22.519-526.SCI |
48. Liu Z# , Li Y# , Tian X# , Liu Q#, Li E#, Gu X#, Liu M#, Xu J, He Z, Huang Y, Xu S, Lai G, Chen Y, Zhang X, Zhang T, Xu J, Zhu L, Qu J*, Cao B*.Airway-invasion-associated pulmonary computed tomography presentations characteristic of invasive pulmonary Aspergillosis in non-immunocompromised adults: a National Multicenter Retrospective Survey in China.Respir Res.2020.21(1).173.SCI |
49. Wu X#, Yao D, Bao L , Liu D, Xu X, An Y , Zhang X*, Cao B*.Ficolin A derived from local macrophages and neutrophils protects against lipopolysaccharide-induced acute lung injury by activating complement.Immunol Cell Biol.2020.98(7).595-606.SCI |
50. Liu C#, Du P, Zhao J, Li B, Wang C, Sun L, Lu B, Wang Y, Liu Y, Cao B*.Phenotypic and Genomic Characterization of Virulence Heterogeneity in Multidrug-Resistant ST11 Klebsiella pneumoniae During Inter-Host Transmission and Evolution.Infect Drug Resist.2020.13.1713-1721.SCI |
51. Shang L﹟, Xu J, Cao B*.Viral pneumonia in China: from surveillance to response.Lancet Public Health.2020.5(12).e633-e634.SCI |
52. Li H﹟, Ren L﹟, Zhang L﹟, Wang Y﹟, Guo L﹟, Wang C, Xiao Y, Wang Y, Rao J, Wang X, Liu Y, Huang C, Gu X, Fan G, Li H, Lu B, Cao B*, Wang J*.High Anal Swab Viral Load Predisposes Adverse Clinical Outcomes in Severe COVID-19 Patients.Emerg Microbes Infect.2020.9(1).2707-2714.SCI |
53. Shu H﹟, Li L, Wang Y, Guo Y, Wang C, Yang C, Gu L*, Cao B*.Prediction of the Risk of Hospital Deaths in Patients with Hospital-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii Infection: A Multi-Center Study.Infect Drug Resist.2020.13.4147-4154.SCI |
54. Wang Y﹟, Zhong W﹟, Salam A﹟, Tarning J﹟, Zhan Q﹟, Huang JA﹟, Weng H, Bai C, Ren Y, Yamada K, Wang D, Guo Q, Fang Q, Tsutomu S, Zou X, Li H, Gillesen A, Castle L, Chen C, Li H, Zhen J, Lu B, Duan J, Guo L, Jiang J, Cao R, Fan G, Li J, Hayden FG, Wang C, Horby P, Cao B*.Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza.EBioMedicine.2020.62.103125.SCI |
55. Zhang Y﹟, Li Y, Zeng J, Chang Y, Han S, Zhao J, Fan Y, Xiong Z, Zou X, Wang C, Li B, Li H, Han J, Liu X, Xia Y, Lu B*, Cao B*.Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality.Infect Drug Resist.2020.13.4115-4123.SCI |
56. Fan G#, Tu C# , Zhou F#, Liu Z#, Wang Y#, Song B , Gu X, Wang Y , Wei Y, Li H, Wu X , Xu J, Tu S , Zhang Y, Wu W* , Cao B*.Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study.Eur Respir J.2020.56(3).2002113.SCI |
57. Sun Y﹟, Li H﹟, Pei Z, Wang S, Feng J, Xu L, Gao P, Cao B,* Zhan S*.Incidence of community-acquired pneumonia in urban China: A national population-based study.Vaccine.2020.38(52).8362-8370.SCI |
58. Liu S #, Li H, Wang Y, Li H, Du S,Zou X, Zhang X, Cao B*.High Expression of IL-36g in Influenza Patients Regulates Interferon Signaling Pathway and Causes Programmed Cell Death During Influenza Virus Infection. Frontiers in Immunology.Frontiers in Immunology.2020.11.552606.SCI |
59. Wang Y﹟, Gu X, Xu J, Cao B*, Wang C.Remdesivir and COVID-19 - Authors' reply.Lancet.2020.396(10256).954.SCI |
60. Li H#, Liu L, Zhang D, Xu J, Dai H, Tang N, Su X, Cao B*.SARS-CoV-2 and viral sepsis: observations and hypotheses.Lancet.2020.395(10235).1517-1520.SCI |
61. Huang C#, Wang Y#, Li X#, Ren L#, Zhao J#, Hu Y#, Zhang L#, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J*, Cao B*. .Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China..Lancet.2020.395 (10223).497-506.SCI |
62. Cao B#*, Wang Y#, Wen D#, Liu W#, Wang J#, Fan G#, Ruan L#, Song B#, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H , Shang L , Wang K , Li K , Zhou X , Dong X , Qu Z , Lu S , Hu X , Ruan S , Luo S , Wu J , Peng L , Cheng F , Pan L , Zou J , Ji.A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19..N Engl J Med.2020.382(19).1787-1799.SCI |
63. Wang Y#, Fan G#, Salam A, Horby P, Hayden FG, Chen C, Pan J, Zheng J, Lu B, Guo L, Wang C, Cao B*; CAP-China Network..Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection..J Infect Dis.2020.221(10).1688-1698.SCI |
64. Gao C#, Wang Y#, Gu X#, Shen X, Zhou D, Zhou S, Huang JA, Cao B*, Guo Q*; for the Community-Acquired Pneumonia–China Network.Association Between Cardiac Injury and Mortality in Hospitalized Patients Infected With Avian Influenza A (H7N9) Virus.Crit Care Med.2020.48(4).451-458.SCI |
65. Zhang Y#, Wang Y, Zhao J, Xiong Z, Fan Y, Zhang W, Zou X, Wang C, Han J, Li B, Lu B, Cao B*, CAP-China Network.Severity and mortality of respiratory syncytial virus vs influenza A infection in hospitalized adults in China.Influenza Other Respir Viruses.2020.14(5).483-490.SCI |
66. Zhang Y﹟, Zhao J﹟, Zou X, Fan Y, Xiong Z, Li B, Wang C, Li H, Han J, Liu X, Xia Y, Lu B*, Cao B*; CAP-China network.Severity of influenza virus and respiratory syncytial virus coinfections in hospitalized adult patients.J Clin Virol.2020.133.104685.SCI |
67. Zou X#, Chang K, Wang Y, Li M, Zhang W, Wang C, Lu B, Xiong Z, Han J, Zhang Y, Zhao J, Cao B*; for CAP-China Network.Comparison of the Cepheid Xpert Xpress Flu/RSV assay and commercial real-time PCR for the detection of influenza A andinfluenza B in a prospective cohort from China.Int J Infect Dis.2019.80.92-97.SCI |
68. Wang J#, Cao B*..Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance. .Curr Opin Pulm Med.2019.25 (2).158-164.SCI |
69. Wang Y#, Fan G, Horby P, Hayden F, Li Q, Wu Q, Zou X, Li H, Zhan Q, Wang C, Cao B*; CAP-China Network. .Comparative Outcomes of Adults Hospitalized With Seasonal Influenza A or B Virus Infection: Application of the 7-Category Ordinal Scale.Open Forum Infect Dis.2019.6(3).ofz053.SCI |
70. Shi Y#, Huang Y#, Zhang TT#, Cao B#, Wang H#, Zhuo C#, Ye F#, Su X#, Fan H#, Xu JF#, Zhang J#, Lai GX#, She DY#, Zhang XY, He B, He LX, Liu YN, Qu JM*. .Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition)..J Thorac Dis.2019.11(6).2581-2616.SCI |
71. Duan S#,Gu X#,Fan G,Sun R,Wang Y,Yu D,Li H,Xiong Z,Lu B,Zhu G,Cao B*..Evaluation of a molecular point of care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: A randomized Clinical Trial.. Clin Microbiol and Infect.2019.25(11).1415-1421.SCI |
72. Zhou F#, Wang Y#, Liu Y#, Liu X#, Gu L#, Zhang X#, Pu Z#, Yang G#, Liu B#, Nie Q, Xue B, Feng J, Guo Q, Liu J, Fan H, Chen J, Zhang Y, Xu Z, Pang M, Chen Y, Nie X, Cai Z, Xu J, Peng K, Li X, Xiang P, Zhang Z, Jiang S, Su X, Zhang J, Li Y, Jin X, Jiang R, Dong J, Song Y, Zhou H, Wang C, Cao B*;.Disease severity and clinical outcomes of community acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicenter prospective registry study from CAP-China Network..European Respiratory Journal .2019.54(2).1802406.SCI |
73. Cheng ZT# ; Yan YQ# ; Jing SP ; Li WG ; Chen WW ; Zhang J; Li M; Zhao S ; Cao N; Ou JX; Zhao SH; Wu XB*; Cao B*; Zhang QW* .Comparative Genomic Analysis of Re-emergent Human Adenovirus Type 55 Pathogens Associated With Adult Severe Community-Acquired Pneumonia Reveals Conserved Genomes and Capsid Proteins[J]. Frontiers in Microbiology.2018.9.1180.SCI |
74. Zhou F#, Gu L, Qu JX, Liu YM, Cao B*.Evaluating the utility of Binax NOW Streptococcus pneumoniae urinary antigen test in adults with community acquired pneumonia in China.Clin Respir J.2018.12(2).425-432.SCI |
75. Guo LP# ; Jiang Y ; Liu YM ; Cao B*.First assessment of interferon gamma release assay results among healthcare workers at a general hospital in China[J].The Clinical Respiratory Journal.2018.12(11).2581-2589.SCI |
76. Liu M#, Li H, Xue CX, Gu L, Qu JX, Yu XM, Wang YM, Liu YM, Cao B*.Differences in inflammatory marker patterns for adult community-acquired pneumonia patients induced by different pathogens.Clin Respir J.2018.12(3).974-985.SCI |
77. Zou XH# ; Fan YY ; Zhang W ; Lu BH ; Liu YM ; Cao B*.Metagenomics facilitated complete genome sequencing of adenovirus untyped by real-time PCR[J].Journal of Infection.2018.77(2).158-164.SCI |
78. Huang L#, Zhang W#, Yang Y#, Wu W#, Lu W#, Xue H, Zhao H, Wu Y, Shang J, Cai L, Liu L, Liu D, Wang Y, Cao B*, Zhan Q*, Wang C.Application of extracorporeal membrane oxygenation in patients with severe acute respiratory distress syndrome induced by avian influenza A (H7N9) viral pneumonia: national data from the Chinese multicentre collaboration. BMC Infect Dis.2018.18(1).23.SCI |
79. Han X#, Zhou F, Li H, Xing X, Chen L, Wang Y, Zhang C, Liu X, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu M, Xue C, Liu B, Zhu X, Li Y, Xiao Y, Cui X, Li L, Purdy JE, Cao B*. Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia.BMC Infect Dis.2018.18(1).192.SCI |
80. Wang Y#, Guo Q#, Yan Z#, Zhou D#, Zhang W#, Zhou S#, Li Y-P#, Yuan J#, Uyeki TM#, Shen X#, Wu W#, Zhao H, Wu Y-F, Shang J, He Z, Yang Y, Zhao H, Hong Y, Zhang Z, Wu M, Wei T, Deng X, Deng Y, Cai L, Lu W, Shu H, Zhang L, Luo H, ing Zhou Y, Weng H, Song K, Yao L, Jiang M, Zhao B, Chi R, Guo B, Fu L, Y.Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection.J Infect Dis.2018.217(11).1708-1717.SCI |
81. Jia X#, Liu B#, Bao L#, Lv Q, Li F, Li H, An Y, Zhang X*, Cao B*, Wang C*.Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration. PLoS Pathog.2018.14(11).e1007428.SCI |
82. Yu D#, Zhang G, Gao L, Xu W, Cao B*.High ratio of measles-specific IgG/IgM associated with nodular pneumonia in vaccinated individuals. Int J Infect Dis.2018.76.38-44.SCI |
83. Cao B#*, Huang Y#, She D-Y, Cheng Q-J, Fan H, Tian X-L, Xu J-F, Zhang J, Chen Y, Shen N, Wang H, Jiang M, Zhang X-Y, Shi Y, He B, He L-X, Liu Y-N, Qu J-M*. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.Clin Respir J.2018.12(4).1320-1360.SCI |
84. Li H#, Bradley KC#, Long JS, Frise R, Ashcroft JW, Hartgroves LC, Shelton H, Makris S, Johansson C, Cao B*, Barclay WS*.Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice.[J].Plos Pathogens.2018.14(1).e1006821.SCI |
85. Chen L#, Zhou F, Li H, Xing X, Han X, Wang Y, Zhang C, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu M, Xue C, Liu B, Zhu X, Li Y, Xiao Y, Cui X, Li L, Uyeki TM, Wang C, Cao B*.Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey.BMJ Open.2018.8(2).e018709 .SCI |
86. Zou X#, Guo Q#, Zhang W#, Chen H, Bai W, Lu B, Zhang W, Fan Y, Liu C, Wang Y, Zhou F, Cao B*.Dynamic Variation and Reversion in the Signature Amino Acids of H7N9 Virus During Human Infection.J Infect Dis.2018.218(4).586-594.SCI |
87. Zhou F#, Li H, Gu L, Liu M, Xue C, Cao B*, Wang C. Risk factors for nosocomial infection among hospitalised severe influenza A(H1N1)pdm09 patients.Respir Med.2018.134.86-91.SCI |
88. Zhang Y#, Wang Q#, Yin Y, Chen H, Jin L, Gu B, Xie L, Yang C, Ma X, Li H, Li W, Zhang X, Liao K, Man S, Wang S, Wen H, Li B, Guo Z, Tian J, Pei F, Liu L, Zhang L, Zou C, Hu T, Cai J, Yang H, Huang J, Jia X, Huang W, Cao B*, Wang H*. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.Antimicrob Agents Chemother.2018.62(2).e01882-17.SCI |
89. Li H#, Yang S, Gu L, Zhang Y, Yan X, Liang Z, Zhang W, Jia H, Chen W, Liu M, Yu K, Xue C, Hu K, Zou Q, Li L, Cao B*, Wang C.Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respi Viruses.2017.11(4).345-354.SCI |
90. Li H#, Cao B*.Pandemic and Avian Influenza A Viruses in Humans: Epidemiology, Virology, Clinical Characteristics, and Treatment Strategy. Clin Chest Med.2017.38(1).59-70.SCI |
91. Guo L#, Li G, Wang J, Zhao X, Wang S, Zhai L, Jia H, Cao B*.. Suspicious outbreak of ventilator-associated pneumonia caused by Burkholderia cepacia in a surgical intensive care unit.Am J Infect Control.2017.45(6).660-666.SCI |
92. Yin YD#, Wang R, Zhuo C, Wang H, Wang MG, Xie CM, She DY, Yuan X, Wang RT, Cao B*, Liu YN*.Macrolide-resistant Mycoplasma pneumoniae prevalence and clinical aspects in adult patients with community-acquired pneumonia in China: a prospective multicenter surveillance study[J].J Thorac Dis.2017.9(10).3774-3781.SCI |
93. Xue C#, Wen M#, Bao L#, Li H, Li F, Liu M, Lv Q, An Y, Zhang X*, Cao B*.Vγ4+γδT Cells Aggravate Severe H1N1 Influenza Virus Infection-Induced Acute Pulmonary Immunopathological Injury via Secreting Interleukin-17A.Front Immunol.2017.8.1054.SCI |
94. Shi SJ#, Li H, Liu M, Liu YM, Zhou F, Liu B, Qu JX, Cao B*.Mortality prediction to hospitalized patients with influenza pneumonia: PO 2 /FiO 2 combined lymphocyte count is the answer.Clin Respir J.2017.11(3).352-360.SCI |
95. Cao B#*, Qu J-X#, Yin Y-D#, Eldere J Van#.Overview of antimicrobial options for M ycoplasma pneumoniae pneumonia: focus on macrolide resistance.Clin Respir J.2017.11(4).419-429.SCI |
96. Hu Y.F., Zhang Y., Ren X.W., Liu Y.M., Xiao Y., Li L., Yang F., Su H.X., Liu F., Liu HY.*, Cao B.*, Jin Q*..A case report demonstrating the utility of next generation sequencing in analyzing serial samples from the lung following an infection with influenza A (H7N9) virus.J Clin Virol.2016.76(-).45-50.SCI |
97. Cao B.#*, Gao H.N.#, Zhou B.P.#, Deng X.L.#, Hu C.P.#, Deng C.S., Lu H.Z., Li Y.P., Gan J.H., Liu J.Y., Li H., Zhang Y., Yang Y.D., Fang Q., Shen Y.Z., Gu Q., Zhou X.M., Zhao W., Pu Z.H., Chen L., Sun B.X., Liu X., Hamilton C.D., Li L.J.*.Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia.Crit Care Med.2016.44(6).e318-28.SCI |
98. Shi S.J.#, Li H., Liu M., Liu Y.M., Zhou F., Liu B., Qu J.X., Cao B.*.Mortality prediction to hospitalized patients with influenza pneumonia: PO2/FiO2combined lymphocyte count is the answer.Clin Respir J.2015.11 (3).352-360 .SCI |
99. Hu Y.#, Ren X.#, Liu Y.#, Yang F., Liu H., Cao B.*, Jin Q.*.Serial high-resolution analysis of blood virome and host cytokines expression profile of a patient with fatal H7N9 infection by massively parallel RNA sequencing .Clin Microbiol Infect.2015.21(7).e1-4.SCI |
100. Qu J.X.#, Gu L.#, Pu Z.H., Yu X.M., Liu Y.M., Li R., Wang Y.M., Cao B.*, Wang C..Viral etiology of community-acquired pneumonia among adolescents and adults with mild or moderate severity and its relation to age and severity .BMC Infect Dis.2015.15(2).89.SCI |
101. Cao B.#*, Qu J.X#., Yin Y.D.#, Eldere J.V.#.Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance..Clin Respir J.2015. 11 (4).419-429.SCI |
102. Guo J.#, Huan F.#, Liu J.#, Chen Y.#, Wang W.#, Cao B.#, Zou Z., Liu S., Pan J., Bao C., Zeng M., Xiao H., Gao H., Yang S., Zhao Y., Liu Q., Zhou H., Zhu J., Liu X., Liang W., Yang Y., Zheng S., Yang J., Diao H., Su K., Shao L., Cao H., Wu Y., Zhao M., Tan S., Wang J.,Gao F.G.*, Li L.J.*, Jang C.Y.*.The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes.Sci Rep.2015.5(-).e10942.SCI |
103. Liu Y. M., Li B. B., Zhang Y. Y., Zhang W., Shen H., Li H., Cao B.*.Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China.Antimicrob Agents Chemother.2014.58(9).5379-5385.SCI |
104. Liu B., Zhang X., Deng W., Liu J., Li H., Wen M., Bao L., Qu J., Liu Y., Li F., An Y., Qin C., Cao B.*, Wang C.*.Severe influenza A(H1N1)pdm09 infection induces thymic atrophy through activating innate CD8(+)CD44(hi) T cells by upregulating IFN-gamma.Cell Death Dis.2014.5(-).e1440.SCI |
105. Cao B.#, Huang G. H.#, Pu Z. H., Qu J. X., Yu X. M., Zhu Z., Dong J. P., Gao Y., Zhang Y. X., Li X. H., Liu J. H., Wang H., Xu Q., Li H., Xu W., Wang C.*.Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia. Chest.2014.145(1).79-86.SCI |
106. Wang C.#, Yu H.#, Horby P. W.#, Cao B.#, Wu P., Yang S., Gao H., Li H., Tsang T. K., Liao Q., Gao Z., Ip D. K., Jia H., Jiang H., Liu B., Ni M. Y., Dai X., Liu F., Van Kinh N., Liem N. T., Hien T. T., Li Y., Yang J., Wu J. T., Zheng Y., Leung G. M., Farrar J. J., Cowling B. J., Uyeki T. M., Li L..Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients.Clin Infect Dis.2014.58(8).1095-1103.SCI |
107. Cao B.*.What clinicians should know to fight against the novel avian-origin influenza A (H7N9) virus? .Chin Med J .2013.126 (12).2205-2206.SCI |
108. Cao B. Frederick G.Therapy of H7N9 pneumonia: current perspectives.Anti Infect. Ther.2013.11(11).1123–1126.SCI |
109. Qu J., Gu L., Wu J., Dong J., Pu Z., Gao Y., Hu M., Zhang Y., Gao F., Cao B.*, Wang C..Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia.BMC Infectious Diseases .2013.13(1).172.SCI |
110. Zeng X. C., Zhou L., Shi W., Luo X., Zhang L., Nie Y., Wang J., Wu S., Cao B.*, Cao H.*.Three new antimicrobial peptides from the scorpion Pandinus imperator. Peptides .2013.45(-).28-34.SCI |
111. Li F., Wu L., Cao B.*, Zhang Y., Li X., Liu Y. .Surveillance of the Prevalence, Antibiotic Susceptibility, and Genotypic Characterization of Invasive Candidiasis in a Teaching Hospital in China between 2006 to 2011.BMC Infectious Diseases .2013.13(1).353.SCI |
112. Gao H. N.#, Lu H. Z.#, Cao B.#, Du B.#, Shang H.#, Gan J. H., Lu S. H., Yang Y. D., Fang Q., Shen Y. Z., Xi X. M., Gu Q., Zhou X. M., Qu H. P., Yan Z., Li F. M., Zhao W., Gao Z. C., Wang G. F., Ruan L. X., Wang W. H., Ye J., Cao H. F., Li X. W., Zhang W. H., Fang X. C., He J., Liang W. F..Clinical findings in 111 cases of influenza A (H7N9) virus infection.N Engl J Med .2013.368(24).2277-85.SCI |
113. Gao R.#, Cao B.#, Hu Y., Feng Z., Wang D., Hu W., Chen J., Jie Z., Qiu H., Xu K., Xu X., Shen Y., He Z., Gu Y., Zhang Z., Yang Y., Zhao X., Zhou L., Li X., Zou S., Zhang Y., Li X., Yang L., Guo J., Dong J., Li Q., Dong L., Zhu Y., Bai T., Wang S., Hao P., Yang W., Zhan.Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. N Engl J Med .2013.368(20).1888-97.SCI |
114. Ip D. K., Liao Q., Wu P., Gao Z., Cao B., Feng L., Xu X., Jiang H., Li M., Bao J., Zheng J., Zhang Q., Chang Z., Li Y., Yu J., Liu F., Ni M. Y., Wu J. T., Cowling B. J., Yang W., Leung G. M., Yu H..Detection of mild to moderate influenza A/H7N9 infection by China’s national sentinel surveillance system for influenza-like illness: case series.BMJ.2013.346(-).f3693.SCI |
115. Yin Y. D., Zhao F., Ren L. L., Song S. F., Liu Y. M., Zhang J. Z., Cao B.*.Evaluation of the Japanese Respiratory Society guidelines for the identification of Mycoplasma pneumoniae pneumonia.Respirology.2012.17(7).1131-1136.SCI |
116. Liu Y., Cao B.*, Gu L., Liu K., Feng Z..Successful control of vancomycin-resistant Enterococcus faecium nosocomial outbreak in a teaching hospital in China.Am J Infect Control.2012.40(6).568-571.SCI |
117. Gu L., Liu Z., Li X., Qu J., Guan W., Liu Y., Song S., Yu X., Cao B.*.Severe community-acquired pneumonia caused by adenovirus type 11 in immunocompetent adults in Beijing..Journal of Clinical Virology.2012.54(4).295-301.SCI |
118. Wang C.*, Cao B.*, Liu Q. Q., Zou Z. Q., Liang Z. A., Gu L., Dong J. P., Liang L. R., Li X. W., Hu K., He X. S., Sun Y. H., An Y., Yang T., Cao Z. X., Guo Y. M., Wen X. M., Wang Y. G., Liu Y. L., Jiang L. D. .Oseltamivir vs. the Chinese Traditional Therapy Maxingshigan/Yinqiaosan in the Treatment of H1N1 Influenza: A Randomized Trial .Ann Intern Med.2011.155(4).217-25.SCI |
119. Bai L.#, Gu L.#, Cao B.#, Zhai X. L., Lu M., Lu Y., Liang L. R., Zhang L., Gao Z. F., Huang K. W., Liu Y. M., Song S. F., Wu L., Yin Y. D., Wang C. .Clinical Features of Pneumonia Caused by 2009 Influenza A(H1N1) Virus in Beijing, China.Chest.2011.139(5).1156-64.SCI |
120. Cao B., Ren L. L., Zhao F., Gonzalez R., Song S. F., Bai L., Yin Y. D., Zhang Y. Y., Liu Y. M., Guo P., Zhang J. Z., Wang J. W., Wang C..Viral and M. pneumoniae community acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients.Eur J Clin Microbiol Infect Dis.2010.29(11).1443-1448.SCI |
121. Cao B., Zhao C. J., Yin Y. D., Zhao F., Song S. F., Bai L., Zhang J. Z., Liu Y. M., Zhang Y. Y., Wang H., Wang C..High Prevalence of Macrolide Resistance in Mycoplasma pneumoniae Isolates from Adult and Adolescent Patients with Rrespiratory Tract Infections.Clin Infect Dis.2010.51(2).189-194.SCI |
122. Gu Li#, Cao Bin#, Liu Ying mei, Guo Ping, Song Shufan,Li Ran, Dai Huaping, Wang Chen*.A new Tn1546 type of Van B faecium isolates in mainland China.Diagn Microbiol Infect Dis.2009.63.70-75.SCI |
123. Cao B.#, Li X. W.#, Mao Y.#, Wang J.#, Lu H. Z., Chen Y. S., Liang Z. A., Liang L., Zhang S. J., Zhang B., Gu L., Lu L. H., Wang D. Y., Wang C..Clinical features of the initial influenza A H1N1 2009 cases in China.N Engl J Med.2009.61(26).2507-17.SCI |
124. Cao B., Xingwang L., Yuelong S., Nan J., Shijun C., Xiayuan X., Chen W. .Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus, People’s Republic of China.Emerg Infect Dis.2009.15(9).1418-1422.SCI |
125. Wang Zhen, Cao Bin*, LIU Ying-mei , GU Li , WANG Chen*. Investigation of the prevalence that patients co-colonized or infected with Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: A hospital-based study.Chin Med J.2009.122 (11).1283-1288.SCI |
126. Cao B., Liu Y., Song S., Li R., Wang H., Wang C. .First report of clinical and epidemiological characterisation of vancomycin-resistant enterococci from mainland China.Int J Antimicrob Agents.2008.32(3).279-281.SCI |
127. Cao Bin, Wanghui, Zhu Renyuan, Ning Yongzhong, Xie Xiuli, Xu Yingchun, ZHu Yuanjue,Chenminjun*,.Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.DIAGN MICR INFEC DIS.2006.56(4).351-7.SCI |
128. Bin Cao*, Hui Wang, Peng Wang, Mengtao Li, and Yuanjue Zhu.Clinical parameters and outcomes of Pneumocystis Jiroveci Pneumonia in non-HIV/AIDS patients.Chi Med J.2006. 119 (3).234-237.SCI |